A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development - Report - MDSpire

Exploring Patient Insights and Preferences in Lupus Care to Inform the Development of Treatment Guidelines

  • By

  • Shivani Garg

  • Izzy Hartel

  • Lisa R. Sammaritano

  • Anca Askanase

  • Bonnie L. Bermas

  • Maria Dall'Era

  • Alí Duarte-García

  • Victoria P. Werth

  • Brad Rovin

  • Reem A. Mustafa

  • Amy S. Turner

  • Bené Williams

  • Brian L. Ung

  • Hiya Bhavsar

  • Monique C. Gore-Massy

  • Nahirannette Pulido

  • Natacha Guerrero

  • Natalie M. Smith

  • Wambui Machua

  • Linda T. Hiraki

  • Mary Beth Son

  • July 1, 2026

Share

Clinical Report: Exploring Patient Insights and Preferences in Lupus Care

Background

Lupus nephritis and systemic lupus erythematosus are chronic autoimmune diseases that significantly impact patient quality of life. The American College of Rheumatology has recognized the need for patient insights in guideline development.

Data Highlights

No numerical data or trial data is presented in the source material.

Key Findings

  • Three thematic domains emerged from patient discussions: treatment and monitoring, clinical communication, and improving transparency.
  • Patient engagement is essential for identifying values and priorities that inform clinical practice recommendations.
  • The study involved 28 patients, with 19 unique individuals participating in the Patient Panels.
  • Participants were purposefully recruited to represent diverse cultural, social, and ethnic backgrounds.
  • Facilitated discussions aimed to capture patient experiences and preferences regarding lupus management.

Clinical Implications

Incorporating patient perspectives into guideline development can enhance adherence to treatment and improve patient outcomes. Clinicians should consider these insights when making treatment decisions to ensure a patient-centered approach.

Conclusion

The integration of patient insights into lupus care guidelines is vital for aligning treatment recommendations with patient values and enhancing shared decision-making.

Related Resources & Content

  1. American College of Rheumatology, 2025 ACR Guideline for the Treatment of Systemic Lupus Erythematosus
  2. Frontiers in Immunology, Global perspectives on lupus nephritis: a review of clinical trials and therapeutic innovations
  3. Clinical Rheumatology — Factors Influencing the Selection of Intravenous Infusion versus Subcutaneous Injection in Systemic Lupus Erythematosus: A Study of Physician and Patient Attributes
  4. Clinical Rheumatology — Evaluating Treatment Characteristics: Balancing Functional Capacity and Adverse Effects in Personalized Rheumatoid Arthritis Care
  5. Frontiers in Immunology — From empirical treatment to precision intervention: a multi-database bibliometric analysis of neuropsychiatric systemic lupus erythematosus (2006–2025)
  6. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus - PubMed
  7. Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | New England Journal of Medicine
  8. EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosus - ScienceDirect

Original Source(s)

Related Content